Sativa Nativa S A S

Our story began over five years ago, with two Colombian locals sharing a passion for cannabis as alternative medicine. Sergio Puerta, an international horticulture and extraction specialist, and José Rafael López, an expert in genetic development came together with a common goal: to lead the evolution of cannabis cultivation for natural health in Colombia. At Sativa Nativa we strive to be at the forefront of the medicinal cannabis industry in Colombia and a leading exporter of top quality cannabinoid active pharmaceutical ingredients (API). Our fully vertically integrated model includes the highest global standards in genetic development, greenhouse cultivation, extraction, processing and manufacturing of medical cannabis products all in our facility in Santa Marta. We are a subsidiary of Avicanna Inc., a biotechnology company focused on innovative advancements in the medical cannabis industry. Based out of Toronto, Canada, Avicanna leverages its executive management and scientific team's extensive biotechnology and pharmaceutical experience to develop and execute its multilevel and multi-market strategic approach towards medical cannabis. Sativa Nativa leverages Avicanna's scientific team, GMP-level operating standards and proprietary cannabinoid delivery mechanisms along with Avicanna's international distribution network.